Cavo M.; Tacchetti P.; Zamagni E., Expanding CD38-targeting triplets for relapsed or refractory multiple myeloma, «THE LANCET», 2021, 397, pp. 2311 - 2313 [Scientific article]
Rosinol L.; Beksac M.; Zamagni E.; Van de Donk N.W.C.J.; Anderson K.C.; Badros A.; Caers J.; Cavo M.; Dimopoulos M.-A.; Dispenzieri A.; Einsele H.; Engelhardt M.; Fernandez de Larrea C.; Gahrton G.; Gay F.; Hajek R.; Hungria V.; Jurczyszyn A.; Kroger N.; Kyle R.A.; Leal da Costa F.; Leleu X.; Lentzsch S.; Mateos M.V.; Merlini G.; Mohty M.; Moreau P.; Rasche L.; Reece D.; Sezer O.; Sonneveld P.; Usmani S.Z.; Vanderkerken K.; Vesole D.H.; Waage A.; Zweegman S.; Richardson P.G.; Blade J., Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations, «BRITISH JOURNAL OF HAEMATOLOGY», 2021, 194, pp. 496 - 507 [Scientific article]
Zamagni, Elena; Barbato, Simona; Cavo, Michele, How I Treat High-risk Multiple Myeloma, «BLOOD», 2021, blood.2020008733, pp. N/A - N/A [Scientific article]
Anderson K.C.; Auclair D.; Adam S.J.; Agarwal A.; Anderson M.; Avet-Loiseau H.; Bustoros M.; Chapman J.; Connors D.E.; Dash A.; Bacco A.D.; Du L.; Facon T.; Flores-Montero J.; Gay F.; Ghobrial I.M.; Gormley N.J.; Gupta I.; Higley H.; Hillengass J.; Kanapuru B.; Kazandjian D.; Kelloff G.J.; Kirsch I.R.; Kremer B.; Landgren O.; Lightbody E.; Lomas O.C.; Lonial S.; Mateos M.-V.; de Oca R.M.; Mukundan L.; Munshi N.C.; Odonnell E.K.; Orfao A.; Paiva B.; Patel R.; Pugh T.J.; Ramasamy K.; Ray J.; Roshal M.; Ross J.A.; Sigman C.C.; Thoren K.L.; Trudel S.; Ulaner G.; Valente N.; Weiss B.M.; Zamagni E.; Kumar S.K., Minimal residual disease in Myeloma: Application for clinical care and new drug registration, «CLINICAL CANCER RESEARCH», 2021, 27, pp. 5195 - 5212 [Scientific article]Open Access
Solli, Vincenza; Poletti, Andrea; Borsi, Enrica; Martello, Marina; Pantani, Lucia; Armuzzi, Silvia; Vigliotta, Ilaria; Zamagni, Elena; Tacchetti, Paola; Rocchi, Serena; Mancuso, Katia; Mazzocchetti, Gaia; Taurisano, Barbara; Pistis, Ignazia; Cavo, Michele; Terragna, Carolina, OAB-006: A novel algorithm to identify, characterize and define the prognostic impact of complex catastrophic events in Multiple Myeloma, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2021, 21, pp. S4 - S5 [Abstract]
Andrea Poletti, Vincenza Solli, Gaia Mazzocchetti, Marina Martello, Enrica Borsi, Silvia Armuzzi, Ilaria Vigliotta, Barbara Taurisano, Elena Zamagni, Lucia Pantani, Paola Tacchetti, Katia Mancuso, Serena Rocchi , Carolina Terragna , Michele Cavo, OAB-057: Temporal-weight estimation of the copy number alterations of of 1384 Multiple Myeloma patients defines an ancestrality index impacting patients survival, in: Clinical Lymphoma Myeloma and Leukemia. Volume 21, Supplement 2, October 2021, 2021, pp. S35 - S36 (atti di: 18th International Myeloma Workshop, Vienna, Austria, September 8 - 11, 2021) [Contribution to conference proceedings]
Jamet B.; Morvan L.; Nanni C.; Michaud A.-V.; Bailly C.; Chauvie S.; Moreau P.; Touzeau C.; Zamagni E.; Bodet-Milin C.; Kraeber-Bodere F.; Mateus D.; Carlier T., Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2021, 48, pp. 1005 - 1015 [Scientific article]
Zamagni, E.; Dhanasiri, S.; Ghale, A.; Moore, A.; Roussel, M., Real-world analysis of patient characteristics, treatment outcomes, and healthcare resource utilization across Europe in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation who received lenalidomide- or bortezomib-based regimens, «LEUKEMIA & LYMPHOMA», 2021, 62, pp. 2492 - 2501 [Scientific article]Open Access
Zamagni E.; Nanni C.; Dozza L.; Carlier T.; Bailly C.; Tacchetti P.; Versari A.; Chauvie S.; Gallamini A.; Gamberi B.; Caillot D.; Patriarca F.; Macro M.; Boccadoro M.; Garderet L.; Barbato S.; Fanti S.; Perrot A.; Gay F.; Sonneveld P.; Karlin L.; Cavo M.; Bodet-Milin C.; Moreau P.; Kraeber-Bodere F., Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma, «JOURNAL OF CLINICAL ONCOLOGY», 2021, 39, pp. 116 - 125 [Scientific article]
Rizzello, I.; Cavo, M.; Dozza, L.; Rivolti, E.; Petrucci, M. T.; De Stefano, V.; Antonioli, E.; Tosi, P.; D'Agostino, M.; More, S.; Gozzetti, A.; Cea, M.; Barbato, S.; Tacchetti, P.; Pantani, L.; Mancuso, K.; Rocchi, S.; De Cicco, G.; Fusco, A.; Zamagni, E., Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study, «LEUKEMIA & LYMPHOMA», 2021, 62, pp. 1897 - 1906 [Scientific article]
Terpos E.; Zamagni E.; Lentzsch S.; Drake M.T.; Garcia-Sanz R.; Abildgaard N.; Ntanasis-Stathopoulos I.; Schjesvold F.; de la Rubia J.; Kyriakou C.; Hillengass J.; Zweegman S.; Cavo M.; Moreau P.; San-Miguel J.; Dimopoulos M.A.; Munshi N.; Durie B.G.M.; Raje N., Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group, «THE LANCET ONCOLOGY», 2021, 22, pp. e119 - e130 [Scientific article]
Moreau P.; Kumar S.K.; San Miguel J.; Davies F.; Zamagni E.; Bahlis N.; Ludwig H.; Mikhael J.; Terpos E.; Schjesvold F.; Martin T.; Yong K.; Durie B.G.M.; Facon T.; Jurczyszyn A.; Sidana S.; Raje N.; van de Donk N.; Lonial S.; Cavo M.; Kristinsson S.Y.; Lentzsch S.; Hajek R.; Anderson K.C.; Joao C.; Einsele H.; Sonneveld P.; Engelhardt M.; Fonseca R.; Vangsted A.; Weisel K.; Baz R.; Hungria V.; Berdeja J.G.; Leal da Costa F.; Maiolino A.; Waage A.; Vesole D.H.; Ocio E.M.; Quach H.; Driessen C.; Blade J.; Leleu X.; Riva E.; Bergsagel P.L.; Hou J.; Chng W.J.; Mellqvist U.-H.; Dytfeld D.; Harousseau J.-L.; Goldschmidt H.; Laubach J.; Munshi N.C.; Gay F.; Beksac M.; Costa L.J.; Kaiser M.; Hari P.; Boccadoro M.; Usmani S.Z.; Zweegman S.; Holstein S.; Sezer O.; Harrison S.; Nahi H.; Cook G.; Mateos M.-V.; Rajkumar S.V.; Dimopoulos M.A.; Richardson P.G., Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group, «THE LANCET ONCOLOGY», 2021, 22, pp. e105 - e118 [Scientific article]
Musto P.; Engelhardt M.; Caers J.; Bolli N.; Kaiser M.; van de Donk N.; Terpos E.; Broijl A.; de Larrea C.F.; Gay F.; Goldschmidt H.; Hajek R.; Vangsted A.J.; Zamagni E.; Zweegman S.; Cavo M.; Dimopoulos M.; Einsele H.; Ludwig H.; Barosi G.; Boccadoro M.; Mateos M.-V.; Sonneveld P.; Miguel J.S., 2021 European myeloma network review and consensus statement on smoldering multiple myeloma: How to distinguish (and manage) Dr. Jekyll and Mr. Hyde, «HAEMATOLOGICA», 2021, 106, pp. 2799 - 2812 [Scientific article]Open Access
Mattia D'Agostino, Juan-José Lahuerta, Ruth Wester, Anders Waage, Uta Bertsch, Elena Zamagni, Maria-Victoria Mateos, Alessandra Larocca, Daniele Dall'Olio, Niels W.C.J. Van De Donk, David Cairns, Serena Rocchi, Hans Salwender, Joan Blade Creixenti, Bronno van der Holt, Castellani Gastone, Giovannino Ciccone, Andrea Capra, Jan Dürig, Sara Bringhen, Sonja Zweegman, Michele Cavo, Hartmut Goldschmidt, Gordon Cook, Jesus Maria Hernández-Rivas, Jesus F. San-Miguel, Mario Boccadoro and Pieter Sonneveld, A new risk stratification model (R2-ISS) in Newly Diagnosed Multiple Myeloma: Analysis of Mature Data from 7077 patients collected by European Myeloma Network Within HARMONY Big Data Platform, in: 62nd ASH Annual Meeting & Exposition, 2020(atti di: 62nd ASH Annual Meeting & Exposition, All-virtual event, December 5-8,2020) [Poster]
Mattia D'agostino, Juan José Lahuerta, Anders Waage, Uta Bertsch, Elena Zamagni, Maria-Victoria Mateos, Alessandra Larocca, Daniele Dall'Olio, Niels WCJ van de Donk, Hans Salwender, Joan Bladé, Bronno van der Holt, Gastone Castellani, Giovannino Ciccone, Jan Dürig, Sara Bringhen, Sonja Zweegman, Michele Cavo, Hartmut Goldschmidt, Jesús María Hernandez Rivas, Jesus San Miguel, Mario Boccadoro, Pieter Sonneveld, A NEW RISK STRATIFICATION STRATEGY IN NEWLY DIAGNOSED MULTIPLE MYELOMA: AN ANALYSIS ON MATURE DATA FROM EUROPEAN CLINICAL TRIALS WITHIN THE HARMONY BIG DATA PLATFORM, in: Abstract Book: 25th Congress of the European Hematology Association Virtual Edition, 2020, «HEMASPHERE», 2020, 4, pp. 421 - 422 (atti di: 25th Congress of the European Hematology Association - 25th EHA Congress, Virtual edition, June 11-22, 2020) [Abstract]Open Access
